Annual Working Capital
$11.38 M
-$25.93 M-69.49%
31 December 2022
Summary:
Catalyst Biosciences annual working capital is currently $11.38 million, with the most recent change of -$25.93 million (-69.49%) on 31 December 2022. During the last 3 years, it has fallen by -$60.33 million (-84.13%).CBIO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$3.35 M
-$1.48 M-30.62%
30 September 2023
Summary:
Catalyst Biosciences quarterly working capital is currently $3.35 million, with the most recent change of -$1.48 million (-30.62%) on 30 September 2023.CBIO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -84.1% | -94.1% |
| 5 y5 years | -90.5% | -95.8% |
CBIO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -94.7% | -98.4% |
Catalyst Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $3.35 M(-30.6%) |
| June 2023 | - | $4.83 M(-32.7%) |
| Mar 2023 | - | $7.17 M(-37.0%) |
| Dec 2022 | $11.38 M(-69.5%) | $11.38 M(-60.2%) |
| Sept 2022 | - | $28.60 M(-62.9%) |
| June 2022 | - | $77.00 M(+227.5%) |
| Mar 2022 | - | $23.51 M(-37.0%) |
| Dec 2021 | $37.31 M(-48.0%) | $37.31 M(-34.2%) |
| Sept 2021 | - | $56.71 M(-30.2%) |
| June 2021 | - | $81.26 M(-20.6%) |
| Mar 2021 | - | $102.34 M(+42.7%) |
| Dec 2020 | $71.71 M(+6.8%) | $71.71 M(-21.3%) |
| Sept 2020 | - | $91.15 M(-15.3%) |
| June 2020 | - | $107.68 M(+11.7%) |
| Mar 2020 | - | $96.42 M(+43.6%) |
| Dec 2019 | $67.17 M(-43.6%) | $67.17 M(-16.1%) |
| Sept 2019 | - | $80.06 M(-12.8%) |
| June 2019 | - | $91.86 M(-12.2%) |
| Mar 2019 | - | $104.63 M(-12.2%) |
| Dec 2018 | $119.19 M(+292.5%) | $119.19 M(-8.0%) |
| Sept 2018 | - | $129.50 M(-5.2%) |
| June 2018 | - | $136.54 M(-4.2%) |
| Mar 2018 | - | $142.53 M(+369.3%) |
| Dec 2017 | $30.37 M(+95.2%) | $30.37 M(+23.6%) |
| Sept 2017 | - | $24.57 M(-18.1%) |
| June 2017 | - | $29.99 M(+125.3%) |
| Mar 2017 | - | $13.31 M(-14.4%) |
| Dec 2016 | $15.56 M(-49.7%) | $15.56 M(-17.2%) |
| Sept 2016 | - | $18.78 M(-17.1%) |
| June 2016 | - | $22.66 M(-17.3%) |
| Mar 2016 | - | $27.41 M(-11.4%) |
| Dec 2015 | $30.94 M(-70.6%) | $30.94 M(-11.5%) |
| Sept 2015 | - | $34.95 M(-64.5%) |
| June 2015 | - | $98.55 M(-2.7%) |
| Mar 2015 | - | $101.33 M(-3.7%) |
| Dec 2014 | $105.23 M | $105.23 M(+9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $95.78 M(+5.0%) |
| June 2014 | - | $91.25 M(+3.0%) |
| Mar 2014 | - | $88.61 M(+7.2%) |
| Dec 2013 | $82.63 M(-29.0%) | $82.63 M(-6.1%) |
| Sept 2013 | - | $87.95 M(-6.3%) |
| June 2013 | - | $93.92 M(-9.0%) |
| Mar 2013 | - | $103.25 M(-11.3%) |
| Dec 2012 | $116.39 M(-2.7%) | $116.39 M(-15.8%) |
| Sept 2012 | - | $138.29 M(-5.3%) |
| June 2012 | - | $146.09 M(+11.4%) |
| Mar 2012 | - | $131.15 M(+9.7%) |
| Dec 2011 | $119.61 M(+0.2%) | $119.61 M(-2.9%) |
| Sept 2011 | - | $123.23 M(-16.7%) |
| June 2011 | - | $147.96 M(+38.3%) |
| Mar 2011 | - | $106.97 M(-10.4%) |
| Dec 2010 | $119.42 M(-44.0%) | $119.42 M(-13.0%) |
| Sept 2010 | - | $137.23 M(-7.5%) |
| June 2010 | - | $148.34 M(-26.7%) |
| Mar 2010 | - | $202.49 M(-5.0%) |
| Dec 2009 | $213.20 M(+172.7%) | $213.20 M(+227.8%) |
| Sept 2009 | - | $65.03 M(+2.4%) |
| June 2009 | - | $63.48 M(-13.0%) |
| Mar 2009 | - | $72.93 M(-6.7%) |
| Dec 2008 | $78.17 M(+1.2%) | $78.17 M(-7.4%) |
| Sept 2008 | - | $84.44 M(-9.0%) |
| June 2008 | - | $92.74 M(+10.5%) |
| Mar 2008 | - | $83.93 M(+8.7%) |
| Dec 2007 | $77.22 M(+10.5%) | $77.22 M(-6.0%) |
| Sept 2007 | - | $82.16 M(+40.7%) |
| June 2007 | - | $58.39 M(-9.3%) |
| Mar 2007 | - | $64.40 M(-7.9%) |
| Dec 2006 | $69.90 M(+240.5%) | $69.90 M(+29.2%) |
| Sept 2006 | - | $54.12 M(-8.5%) |
| June 2006 | - | $59.13 M(+145.0%) |
| Mar 2006 | - | $24.14 M(+17.6%) |
| Dec 2005 | $20.53 M(-59.0%) | $20.53 M |
| Dec 2004 | $50.08 M | - |
FAQ
- What is Catalyst Biosciences annual working capital?
- What is the all time high annual working capital for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Catalyst Biosciences?
What is Catalyst Biosciences annual working capital?
The current annual working capital of CBIO is $11.38 M
What is the all time high annual working capital for Catalyst Biosciences?
Catalyst Biosciences all-time high annual working capital is $213.20 M
What is Catalyst Biosciences quarterly working capital?
The current quarterly working capital of CBIO is $3.35 M
What is the all time high quarterly working capital for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly working capital is $213.20 M